EZH2 and breast cancer: To validate the phosphorylation status of EZH2 in invasive metastatic BC, we examined pEZH2-T487 and pEZH2-S21 expression by immunofluorescence two individual HER2-positive BC chest recurrence case tissue after multi-line anti-HER2 treatment.